Rankings
▼
Calendar
BHVN FY 2024 Earnings — Biohaven Ltd. Revenue & Financial Results | Market Cap Arena
BHVN
Biohaven Ltd.
$1B
FY 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$885M
Net Income
-$846M
EPS (Diluted)
$-9.28
Cash Flow
Operating Cash Flow
-$582M
Free Cash Flow
-$587M
Stock-Based Comp.
$72M
Balance Sheet
Total Assets
$615M
Total Liabilities
$192M
Stockholders' Equity
$423M
Cash & Equivalents
$99M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$885M
-$436M
-103.0%
Net Income
-$846M
-$408M
-107.4%
← Q4 2023
All Quarters
Q1 2024 →